FDA blasts Lonza facility in Form 483 that derailed Bristol Myers’ plan of liso-cel nod by 2020 aliu […]
Category: Uncategorized
Eli Lilly’s COVID-19 antibody picks up $871M in Q4—and carries blockbuster hopes for 2021 esagonowsky Fri, 01/29/2021 – […]
A team from the Gamma and Neutron Spectroscopy Group of the Corpuscular Physics Institute (IFIC) has patented a […]
The treatment of cancer with new, individualized cell therapies is usually very costly and lengthy. Before treatment can […]
It’s tempting, isn’t it? If you’re a couple of doctors, it’s hard to resist getting home from a […]
WCLC: AstraZeneca, Daiichi Sankyo’s Enhertu shows more phase 2 lung cancer promise chelfand Thu, 01/28/2021 – 23:59
Meanwhile, Phase IIb results from South Africa trial demonstrated 60% efficacy
Datopotamab deruxtecan and Enhertu were evaluated in non-small cell lung cancer patients
Speciality vaccine company has also started production of vaccine candidate
